These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25082574)

  • 21. Why surgery won the SYNTAX trial and why it matters.
    Mack M; Baumgarten H; Lytle B
    J Thorac Cardiovasc Surg; 2016 Nov; 152(5):1237-1240. PubMed ID: 27283748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease.
    Naqvi SY; Klein J; Saha T; McCormick DJ; Goldberg S
    Am J Cardiol; 2017 Feb; 119(4):520-527. PubMed ID: 28012553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary artery bypass surgery is superior to second generation drug-eluting stents in three-vessel coronary artery disease: a propensity score matched analysis.
    Tsuneyoshi H; Komiya T; Kadota K; Shimamoto T; Sakai J; Hiraoka T; Wada K; Kaneko H; Fujimoto Y; Furuichi Y; Hata R; Jinno T; Tominaga O
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):462-468. PubMed ID: 28874027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-Analysis of Percutaneous Coronary Intervention With Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Isolated Proximal Left Anterior Descending Coronary Disease.
    Kinnaird T; Kwok CS; Narain A; Butler R; Ossei-Gerning N; Ludman P; Moat N; Anderson R; Mamas MA
    Am J Cardiol; 2016 Oct; 118(8):1171-1177. PubMed ID: 27553097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stent placement versus coronary artery bypass surgery for unprotected left main coronary artery disease: A meta-analysis of randomized controlled trials.
    Upadhaya S; Baniya R; Madala S; Subedi SK; Khan J; Velagapudi RK; Bachuwa G
    J Card Surg; 2017 Feb; 32(2):70-79. PubMed ID: 28081585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE.
    Leacche M; Byrne JG; Solenkova NS; Reagan B; Mohamed TI; Fredi JL; Zhao DX
    J Thorac Cardiovasc Surg; 2013 Apr; 145(4):1004-1012. PubMed ID: 22541514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined Coronary Revascularization: Single-Center 10-Year Experience.
    Aymami M; Ruggieri VG; Rouzé S; Flécher E; Guihaire J; Anselmi A; Harmouche M; Langanay T; Boulmier D; Roisne A; Leguerrier A; Verhoye JP; Corbineau H
    Innovations (Phila); 2016; 11(1):40-5; discussion 45. PubMed ID: 26914670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous or surgical revascularization in multivessel coronary artery disease: synthesis from SYNTAX.
    Taggart DP
    Eur Heart J; 2014 Oct; 35(40):2789-91. PubMed ID: 24970337
    [No Abstract]   [Full Text] [Related]  

  • 31. Hybrid revascularization in multivessel coronary artery disease.
    Repossini A; Tespili M; Saino A; Kotelnikov I; Moggi A; Di Bacco L; Muneretto C
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):288-93; discussion 293-4. PubMed ID: 23444407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revascularization in complex multivessel coronary artery disease after FREEDOM. Is there an indication for PCI and drug-eluting stents?
    Koskinas KC; Windecker S
    Herz; 2016 May; 41(3):224-32. PubMed ID: 27048841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial revascularisation in renal dysfunction: a systematic review and meta-analysis.
    Deo SV; Shah IK; Dunlay SM; Erwin PJ; Dillon JM; Park SJ
    Heart Lung Circ; 2013 Oct; 22(10):827-35. PubMed ID: 23548338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
    Kurlansky P; Herbert M; Prince S; Mack MJ
    Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative one-year effectiveness of percutaneous coronary intervention versus coronary artery bypass grafting in patients <75 versus ≥75 years with unprotected left main disease (from the CUSTOMIZE Registry).
    Capodanno D; Caggegi A; Capranzano P; Milino V; Chisari A; Mangiameli A; Monaco S; Barrano G; Di Salvo ME; Tamburino C
    Am J Cardiol; 2012 Nov; 110(10):1452-8. PubMed ID: 22853983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consideration of Native Coronary Disease Progression in the Decision to Perform Hybrid Coronary Revascularization.
    Rodriguez ML; Glineur D; Ruel M
    Innovations (Phila); 2017; 12(1):1-3. PubMed ID: 28085689
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognosis after revascularization for left main coronary artery disease: insights from the crystal ball.
    Byrne RA; Kastrati A
    Eur Heart J; 2015 May; 36(20):1212-5. PubMed ID: 25784753
    [No Abstract]   [Full Text] [Related]  

  • 40. Identify Unsuitable Patients with Left Main Coronary Artery Disease in Intermediate SYNTAX Scores Treated by Percutaneous Coronary Intervention.
    Zhang C; Zheng Y; Liu X; Cheng Y; Liu Y; Yao Y; Wang X; Xu J
    Heart Surg Forum; 2017 Dec; 20(6):E258-E262. PubMed ID: 29272225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.